Hemoflex

The use of Hemoflex® Combat on the model of juvenile- Arterial and venous hemorrhage with Standard injury of the upper third of the thigh with a full The intersection of the femoral artery and vein in the pig Significantly, in comparison with the control group, Reduced the time of bleeding from the wound and the mass of blood Losses, which indicated a pronounced Hemostatic effect.

s a medical product of a new generation,Intended for first medicalAnd emergency care for temporary stoppageExternal arterial, venous and capillaryBleeding. The main active ingredientIs a chitosan-biopolymer, which has a hemo-Static activity, antibacterialProperties, biocompatibility and ability toBiodegradation.When the Hemoflex® Combat comes into contact with blood,Adhesion and aggregation of negatively chargedThe outer surface of blood cells (primarilyErythrocytes) on a positively charged surfaceHemoflex® Combat, while forming a gel-likeClot, covering the area of ​​damage in the vessel,Which leads to a stop of bleeding.The use of chitosan nanofibers in the composition ofTented multi-layer structure 9 Hemoflex®Combat improves hemostaticEffect, reduces the risk of resumption of bleeding,And also does not cause inflammatory reactions of tissuesOrganism.